Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness

Rachel S. Chong, Miao Li Chee, Yih Chung Tham, Shivani Majithia, Sahil Thakur, Zhen Ling Teo, Zhi Da Soh, Jacqueline Chua, Bingyao Tan, Damon W.K. Wong, Leopold Schmetterer, Charumathi Sabanayagam, Ching Yu Cheng*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Purpose: To evaluate the association between different classes of antihypertensive medication with retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness in a nonglaucomatous multiethnic Asian population. Design: Population-based, cross-sectional study. Participants: A total of 9144 eyes for RNFL analysis (2668 Malays, 3554 Indians, and 2922 Chinese) and 8549 eyes for GC-IPL analysis (2460 Malays, 3230 Indians, and 2859 Chinese) aged 44 to 86 years. Methods: Participants underwent standardized systemic and ocular examinations and interviewer-administered questionnaires for collection of data on medication and other variables. Intraocular pressure (IOP) readings were obtained by Goldmann applanation tonometry before pupil dilation for fundoscopy and OCT imaging. Blood pressure (BP) was measured with an automatic BP monitor. Mean arterial pressure (MAP) was defined as diastolic BP plus 1/3 (systolic BP – diastolic BP). Regression models were used to investigate the association of antihypertensive medication with OCT measurements of RNFL and GC-IPL. Main Outcome Measures: Average and sectoral RNFL and GC-IPL thickness. Results: After adjusting for age, gender, ethnicity, MAP, IOP, body mass index (BMI), and presence of diabetes, we found that participants taking any type of antihypertensive medication (β = −0.83; 95% confidence interval [CI], −1.46 to −0.02; P = 0.01), specifically angiotensin-converting enzyme inhibitors (ACEIs) (β = −1.66; 95% CI, −2.57 to −0.75; P < 0.001) or diuretics (β = −1.38; 95% CI, −2.59 to −0.17; P < 0.05), had thinner average RNFL in comparison with participants who were not receiving antihypertensive treatment. Use of a greater number of antihypertensive medications was significantly associated with thinner average RNFL (P for trend = 0.001). This association was most evident in the inferior RNFL quadrant in participants using ACEIs (β = −2.44; 95% CI, −3.99 to −0.89; P = 0.002) or diuretics (β = −2.76; 95% CI, −4.76 to −0.76; P = 0.007). A similar trend was noted in our analysis of macular GC-IPL thickness. Conclusions: Use of 2 or more antihypertensive medications, ACEI, and diuretics were associated with a loss of structural markers of retinal ganglion cell health in a multiethnic Asian population.

Original languageEnglish
Pages (from-to)393-400
Number of pages8
JournalOphthalmology
Volume128
Issue number3
DOIs
Publication statusPublished - Mar 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 American Academy of Ophthalmology

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • anti-hypertensive
  • GC-IPL
  • glaucoma
  • hypertension
  • medication
  • OCT
  • RNFL
  • systemic medication

Fingerprint

Dive into the research topics of 'Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness'. Together they form a unique fingerprint.

Cite this